Liying Wu
About
In The Last Decade
Liying Wu
22 papers receiving 514 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 323
- Cancer Research 191
- Oncology 102
- Immunology 52
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Liying Wu
This map shows the geographic impact of Liying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liying Wu more than expected).
Fields of papers citing papers by Liying Wu
This network shows the impact of papers produced by Liying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liying Wu. The network helps show where Liying Wu may publish in the future.
Co-authorship network of co-authors of Liying Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Liying Wu. A scholar is included among the top collaborators of Liying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liying Wu. Liying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 28 | |
| 5 | 34 | |
| 6 | 19 | |
| 7 | 10 | |
| 8 | 56 | |
| 9 | CXCL5 contributes to the tumorigenicity of cervical cancer and is post-transcriptionally regulated by miR-577. | 10 |
| 10 | 17 | |
| 11 | 2 | |
| 12 | 31 | |
| 13 | 7 | |
| 14 | 27 | |
| 15 | 96 | |
| 16 | 29 | |
| 17 | 53 | |
| 18 | 42 | |
| 19 | 20 | |
| 20 | [Regulatory effects of peroxisome proliferator-activated receptor gamma on the growth of pancreatic carcinoma]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.